FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416496799> ?p ?o ?g. }

• W2416496799 endingPage "5114" @default.
• W2416496799 startingPage "5114" @default.
• W2416496799 abstract "To determine the efficacy of rectally administered naproxen for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).This double-blind randomized control trial conducted from January 2013 to April 2014 at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran. A total of 324 patients were selected from candidates for diagnostic or therapeutic ERCP by using the simple sampling method. Patients received a single dose of Naproxen (500 mg; n = 162) or a placebo (n = 162) per rectum immediately before ERCP. The overall incidence of PEP, incidence of mild to severe PEP, serum amylase levels and adverse effects were measured. The primary outcome measure was the development of pancreatitis onset of pain in the upper abdomen and elevation of the serum amylase level to > 3 × the upper normal limit (60-100 IU/L) within 24 h after ERCP. The severity of PEP was classified according to the duration of therapeutic intervention for PEP: mild, 2-3 d; moderate 4-10 d; and severe, > 10 d and/or necessitated surgical or intensive treatment, or contributed to death.PEP occurred in 12% (40/324) of participants, and was significantly more frequent in the placebo group compared to the naproxen group (P < 0.01). Of the participants, 25.9% (84/324) developed hyperamylasemia within 2 h of procedure completion, among whom only 35 cases belonged to the naproxen group (P < 0.01). The incidence of PEP was significantly higher in female sex, in patients receiving pancreatic duct injection, more than 3 times pancreatic duct cannulations, and ERCP duration more than 40 min (Ps < 0.01). There were no statistically significant differences between the groups regarding the procedures or factors that might increase the risk of PEP, sphincterotomy, precut requirement, biliary duct injection and number of pancreatic duct cannulations. In the subgroup of patients with pancreatic duct injection, the rate of pancreatitis in the naproxen group was significantly lower than that in the placebo (6 patients vs 23 patients, P < 0.01, RRR = 12%, AR = 0.3, 95%CI: 0.2-0.6). Naproxen reduced the PEP in patients with ≥ 3 pancreatic cannulations (P < 0.01, RRR = 25%, AR = 0.1, 95%CI: 0.1-0.4) and an ERCP duration > 40 min (P < 0.01, RRR = 20%, AR = 0.9, 95%CI: 0.4-1.2).Single dose of suppository naproxen administered immediately before ERCP reduces the incidence of PEP." @default.
• W2416496799 created "2016-06-24" @default.
• W2416496799 creator A5011472002 @default.
• W2416496799 creator A5022138504 @default.
• W2416496799 creator A5037234372 @default.
• W2416496799 creator A5084837698 @default.
• W2416496799 creator A5087592514 @default.
• W2416496799 date "2016-01-01" @default.
• W2416496799 modified "2023-10-16" @default.
• W2416496799 title "Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial" @default.
• W2416496799 cites W120854751 @default.
• W2416496799 cites W1510489616 @default.
• W2416496799 cites W157277899 @default.
• W2416496799 cites W1583708586 @default.
• W2416496799 cites W1976771338 @default.
• W2416496799 cites W1981026485 @default.
• W2416496799 cites W1981233911 @default.
• W2416496799 cites W1985935901 @default.
• W2416496799 cites W1992339580 @default.
• W2416496799 cites W1993265698 @default.
• W2416496799 cites W1994827373 @default.
• W2416496799 cites W2001000901 @default.
• W2416496799 cites W2005426660 @default.
• W2416496799 cites W2005904298 @default.
• W2416496799 cites W2006485837 @default.
• W2416496799 cites W2009762486 @default.
• W2416496799 cites W2017641574 @default.
• W2416496799 cites W2021113083 @default.
• W2416496799 cites W2024974112 @default.
• W2416496799 cites W2025985747 @default.
• W2416496799 cites W2043770856 @default.
• W2416496799 cites W2043813971 @default.
• W2416496799 cites W2060797202 @default.
• W2416496799 cites W2075846267 @default.
• W2416496799 cites W2077699254 @default.
• W2416496799 cites W2083579911 @default.
• W2416496799 cites W2088173899 @default.
• W2416496799 cites W2100650200 @default.
• W2416496799 cites W2101286529 @default.
• W2416496799 cites W2125091092 @default.
• W2416496799 cites W2136099401 @default.
• W2416496799 cites W2137366845 @default.
• W2416496799 cites W2147745728 @default.
• W2416496799 cites W2151044719 @default.
• W2416496799 cites W2153111158 @default.
• W2416496799 cites W2153273780 @default.
• W2416496799 cites W2161122341 @default.
• W2416496799 cites W2161408096 @default.
• W2416496799 cites W2163266167 @default.
• W2416496799 cites W2168046530 @default.
• W2416496799 cites W2172178532 @default.
• W2416496799 cites W2238701147 @default.
• W2416496799 cites W2320210611 @default.
• W2416496799 cites W2329481650 @default.
• W2416496799 cites W371148 @default.
• W2416496799 cites W4232230702 @default.
• W2416496799 cites W4233682670 @default.
• W2416496799 doi "https://doi.org/10.3748/wjg.v22.i21.5114" @default.
• W2416496799 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4886387" @default.
• W2416496799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27275104" @default.
• W2416496799 hasPublicationYear "2016" @default.
• W2416496799 type Work @default.
• W2416496799 sameAs 2416496799 @default.
• W2416496799 citedByCount "19" @default.
• W2416496799 countsByYear W24164967992017 @default.
• W2416496799 countsByYear W24164967992018 @default.
• W2416496799 countsByYear W24164967992019 @default.
• W2416496799 countsByYear W24164967992020 @default.
• W2416496799 countsByYear W24164967992021 @default.
• W2416496799 countsByYear W24164967992022 @default.
• W2416496799 countsByYear W24164967992023 @default.
• W2416496799 crossrefType "journal-article" @default.
• W2416496799 hasAuthorship W2416496799A5011472002 @default.
• W2416496799 hasAuthorship W2416496799A5022138504 @default.
• W2416496799 hasAuthorship W2416496799A5037234372 @default.
• W2416496799 hasAuthorship W2416496799A5084837698 @default.
• W2416496799 hasAuthorship W2416496799A5087592514 @default.
• W2416496799 hasBestOaLocation W24164967991 @default.
• W2416496799 hasConcept C120665830 @default.
• W2416496799 hasConcept C121332964 @default.
• W2416496799 hasConcept C126322002 @default.
• W2416496799 hasConcept C141071460 @default.
• W2416496799 hasConcept C142724271 @default.
• W2416496799 hasConcept C168563851 @default.
• W2416496799 hasConcept C170835558 @default.
• W2416496799 hasConcept C181199279 @default.
• W2416496799 hasConcept C185592680 @default.
• W2416496799 hasConcept C204787440 @default.
• W2416496799 hasConcept C27081682 @default.
• W2416496799 hasConcept C2775967933 @default.
• W2416496799 hasConcept C2778115740 @default.
• W2416496799 hasConcept C2778444009 @default.
• W2416496799 hasConcept C2779960720 @default.
• W2416496799 hasConcept C2779983558 @default.
• W2416496799 hasConcept C2780955771 @default.
• W2416496799 hasConcept C2909698591 @default.
• W2416496799 hasConcept C55493867 @default.
• W2416496799 hasConcept C61511704 @default.

• next